Therapeutic effect of cyclo-oxygenase inhibitors with different isoform selectivity in lipopolysaccharide-induced preterm birth in mice

American Journal of Obstetrics and Gynecology

Volumn 189, Issue 1, 2003, Pages 261-266

  Lee, Pil Ryang ^a   Kim, So Ra ^a   Jung, Bok Kyung ^a   Kim, Kyu Rae ^a   Chung, Ji Youn ^a   Won, Hye Sung ^a   Kim, Ahm ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Cyclo oxygenase; Mouse; Nonsteroidal anti inflammatory drug; Preterm birth

Indexed keywords

BUFFER; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; INDOMETACIN; LIPOPOLYSACCHARIDE; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHATE; PROSTAGLANDIN SYNTHASE INHIBITOR; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SELECTIVITY; FEMALE; INCIDENCE; MOUSE; NEPHROTOXICITY; NONHUMAN; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZATION; STOMACH DISEASE; TOCOLYSIS;

EID: 0038336561     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.485     Document Type: Article

References (27)

1. Copper RL. A multicenter study of preterm birth weight and gestational age-specific mortality. Am J Obstet Gynecol 1993;168:78-84.
2. Arias F, Tomich P. Etiology and outcome of low birth weight and preterm infants. Obstet Gynecol 1982;60:277-81.
3. Romero R, Mazor M, Wu YK, Sirtori M, Oyarzun E, Mitchell MD, et al. Infection in the pathogenesis of preterm labor. Semin Perinatol 1988;12:262-79.
4. Molnar M, Romero R, Hertelendy F. Interleukin-1 and tumor necrosis factor stimulate arachidonic acid release and phospholipid metabolism in human myometrial cells. Am J Obstet Gynecol 1993;169:825-9.
5. Narahara H, Johnston JM. Effects of endotoxins and cytokines on the secretion of platelet-activating factor acetylhydrolase by human decidual macrophages. Am J Obstet Gynecol 1993;169:531-7.
6. Gravett MG, Witkin SS, Haluska GJ, Edwards JL, Cook MJ, Novy MJ. An experimental model of intraamniotic infection and preterm labor in rhesus monkeys. Am J Obstet Gynecol 1994;171:1660-7.
7. Berry SM, Romero R, Gomez R, Puder KS, Ghezzi F, Cotton DB, et al. Premature parturition is characterized by in utero activation of the fetal immune system. Am J Obstet Gynecol 1995;173:1315-20.
8. Rasanen J, Jouppila P. Fetal cardiac function and ductus arteriosus during indomethacin and sulindac therapy for threatened preterm labor: a randomized study. Am J Obstet Gynecol 1995;173:20-5.
9. Panter KR, Hannah ME, Amankwah KS, Ohlsson A, Jefferies AL, Farine D. The effect of indomethacin tocolysis in preterm labor on perinatal outcome: a randomised placebo-controlled trial. BJOG 1999;106:467-73.
10. Mitchell JA, Larkin S, Williams TJ. Cyclooxygenase-2: regulation and relevance in inflammation. Biochem Pharmacol 1995;50:1535-42.
11. Brater DC, Harris C, Redfern JS, Gertz BJ. Renal effects of COX-2-selective inhibitors. Am J Nephrol 2001;21:1-15.
12. Kahn ANM, Paulson SK, Verburg KM, Lefkowith JB, Maziasz TJ. Pharmacology of cyclooxygenase-2 inhibition in the kidney. Kidney Int 2002;61:1210-9.
13. Norton ME, Merrill J, Cooper BAB, Kuller JA, Clyman RI. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993;329:1602-7.
14. Kramer WB, Saade GR, Belfort M, Dorman K, Mayes M, Moise KJ Jr. Randomized, double blind study comparing sulindac to terbutaline: fetal renal and amniotic fluid effects. Am J Obstet Gynecol 1999;180:396-401.
15. Engelhardt G, Bogel R, Schnitzler C, Utzmann R. Meloxicam: influence on arachidonic acid metabolism: part I, in vitro findings. Biochem Pharmacol 1996;51:21-8.
16. Engelhardt G, Bogel R, Schnitzler C, Utzmann R. Meloxicam: influence on arachidonic acid metabolism: part II, in vivo findings. Biochem Pharmacol 1996;51:29-38.
17. Engelhardt G. Pharmacology, ofmeloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2. Br J Rheumatol 1996;35(Suppl):4-12.
18. Yousif MH, Thulesius O. Tocolytic effect of the cyclooxygenase-2 inhibitor, meloxicam: studies on uterine contractions in the rat. J Pharm Pharmacol 1998;50:681-5.
19. Slattery MM, Friel AM, Healy DG, Morrison JJ. Uterine relaxant effects of cyclooxygenase-2 inhibitors in vitro. Obstet Gynecol 2001;98:563-9.
20. Kaga N, Katsuki Y, Obata M, Shibutani Y. Repeated administration of low-dose lipopolysaccharide induces preterm delivery in mice: a model for human parturition and for assessment of the therapeutic ability of drugs against preterm delivery. Am J Obstet Gynecol 1996;174:754-9.
21. Silver RM, Edwin SS, Umar F, Dudley DJ, Branch DW, Mitchell MD. Bacterial lipopolysaccharide-mediated fetal death: the role of interleukin-1. Am J Obstet Gynecol 1997;176:544-9.
22. Dombroski RA, Woodard DS, Harper MJK, Gibbs RS. A rabbit model for bacteria-induced preterm pregnancy loss. Am J Obstet Gynecol 1990;163:1938-43.
23. McDuffie RS Jr, Sherman MP, Gibbs RS. Amniotic fluid tumor necrosis factor-α and interleukin-1 in a rabbit model of bacterially induced preterm pregnancy loss. Am J Obstet Gynecol 1992;167:1583-8.
24. Hirsch E, Saotome I, Hirsch D. A model of intrauterine infection and preterm delivery in mice. Am J Obstet Gynecol 1995;172:1598-603.
25. Swaisgood CM, Zu H, Perkins DJ, Wu S, Garver CL, Zimmerman PD, et al. Coordinate expression of inducible nitric oxide synthase and cyclooxygenase-2 genes in uterine tissues of endotoxin-treated pregnant-mice. Am J Obstet Gynecol 1997;177:1253-62.
26. Gross G, Imamura T, Vogt SK, Wozniak DF, Nelson DM, Sadovsky Y, et al. Inhibition of cyclooxygenase-2 prevents inflammation-mediated preterm labor in the mouse. Am J Physiol Regul Integr Comp Physiol 2000;278:R1415-23.
27. Fidel PL, Romero R, Wolf N, Cutright J, Ramirez M, Araneda H, et al. Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am J Obstet Gynecol 1994;170:1467-75.